A biochemical engineer with over 20 years experience in development ranging from early stages through commercial launch of therapeutics and technologies at both small biopharmaceutical and large pharmaceutical companies. Especially adept at finding cross-functional, phase appropriate and innovative solutions to challenges in both cell culture and downstream processes and facilities associated with moving discovery concepts from pre-clinical through commercialized therapeutics.
A leader who builds high performing teams focused on timely, cost effective solutions for moving projects and technology to critical milestones. Strategic results achieved through financial and project management, risk assessment and mitigation, with a hands-on leadership style that aligns staff to the mission.
An experienced leader actively engaged in technology evaluation, portfolio prioritization and implementation supporting vision and priorities of the executive team. Process and technology development includes application of single use systems to streamline and intensify manufacturing operations while reducing facility capital requirements and lead times. Technologies include in-house as well as vendor based technology development, risk management strategies for new technology evaluation, development and implementation.
Founder and Chair of several non-profit and professional organizations whose missions range from science and technology education, professional development, at-risk youth development programs, and improving health and welfare in under-served countries.
Specialties: Biopharmaceutical, Pharmaceutical, Process Development, GMP Manufacturing for Clinical Studies, Strategic Technology and Innovation Advancement, Project Management, Scale-up, Technology Transfer, Quality, Environmental and Safety Regulatory Compliance; Process Facility Design and Construction